Bethney Seifert, APRN
Psychiatric/Mental Health · Bangor, MENPI 1316480817
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 403 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 403 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Vanda Pharmaceuticals Inc.$789
- Tris Pharma Inc$537
- Idorsia Pharmaceuticals US Inc$378
- Almatica Pharma LLC$373
- plus $3K from 16 others
What the payments were for
- Food & beverage$7,45599%
- Education$1111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 92 | $1,693 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 68 | $1,072 |
| Vanda Pharmaceuticals Inc. | 39 | $789 |
| Tris Pharma Inc | 28 | $537 |
| Idorsia Pharmaceuticals US Inc | 33 | $378 |
| Almatica Pharma LLC | 22 | $373 |
| Otsuka America Pharmaceutical, Inc. | 15 | $337 |
| Lundbeck LLC | 15 | $329 |
| Teva Pharmaceuticals USA, Inc. | 10 | $294 |
| Neurocrine Biosciences, Inc. | 12 | $286 |
| Corium, LLC | 15 | $281 |
| Alkermes, Inc. | 16 | $262 |
| Sunovion Pharmaceuticals Inc. | 13 | $228 |
| Supernus Pharmaceuticals, Inc. | 4 | $154 |
| Indivior Inc. | 6 | $134 |
| Biogen | 1 | $115 |
| Ironshore Pharmaceuticals Inc. | 4 | $95 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Bausch Health US, LLC | 2 | $41 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,567 in reported general payments places this provider in the 95th percentile of 192 psychiatric/mental health providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 21 | $42,981 |
| Invega SustennaPaliperidone Palmitate | 11 | $37,521 |
| Abilify MaintenaAripiprazole | 11 | $28,374 |
| Lamotrigine ErLamotrigine | 23 | $4,911 |
| Vilazodone Hcl | 16 | $1,657 |
| Quetiapine Fumarate | 78 | $1,237 |
| Trazodone Hcl | 64 | $1,155 |
| Carbamazepine ErCarbamazepine | 12 | $774 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 35 | $736 |
| Alprazolam | 113 | $732 |
| Duloxetine Hcl | 46 | $718 |
| Buspirone Hcl | 54 | $624 |
| Lamotrigine | 87 | $623 |
| Donepezil Hcl | 12 | $587 |
| Bupropion XlBupropion Hcl | 12 | $480 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,693 | $42,98121 claims |
| Johnson & JohnsonInvega Sustenna | $14 | $37,52111 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $337 | $28,37411 claims |
| Almatica Pharma LLCSertraline Hcl | $373 | $29229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 192 psychiatric/mental health providers in Maine.
Other psychiatric/mental health in Bangor
- Joyce PetroskyBangor$2K
- Melissa CharetteBangor$1K
- Stephanie RiehlBangor$871
- Amanda DeluckBangor$847
- Ileana VintilaBangor$833
- Kathleen YoungBangor$790
- Stacy GuayBangor$767
- Barbara WombleBangor$506
- Deborah PickeringBangor$501
- Evan MooreBangor$472
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.